Study: A quarter of children in England receive social care services before 18

Apogee Ther­a­peu­tics and Sagimet Bio­sciences of­fered new de­tails on their IPO plans Mon­day morn­ing, say­ing they look to raise $228 mil­lion and $66 mil­lion in

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes